(30 days)
Not Found
Not Found
No
The 510(k) summary describes a disposable needle electrode for EMG, which is a passive device for signal acquisition. There is no mention of any software, algorithms, or data processing that would suggest the use of AI or ML.
No
Explanation: This device is for recording muscle activity (diagnostics), not for providing therapy.
Yes
Explanation: The device is used for Electromyography (EMG) applications, which involves recording muscle activity to diagnose neuromuscular disorders. While it doesn't directly provide a diagnosis, it collects data essential for diagnostic interpretation by a healthcare professional.
No
The device description clearly describes a physical needle electrode and its connection to EMG equipment, indicating it is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "muscle activity recording for Electromyography (EMG) applications." This involves measuring electrical signals from muscles in vivo (within the living body).
- Device Description: The device is a "Single Patient EMG needle electrode" used to "measure an EMG signal when connected to the EMG equipment." This further confirms its use for in vivo measurement.
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. This device does not operate on such samples.
Therefore, the Neuroline Disposable Monopolar needle electrode is a medical device used for in vivo physiological measurement, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
Ambu Neuroline Disposable Monopolar needle electrodes is used for electromyography (EMG) recording for examination of the peripheral neuromuscular system, by registration of the electrical activity from the muscles. This is used to assess whether muscle impairment is due to disturbances in the motor neurones, the motor nerve fibres or in the muscle itself. It is used mainly to tell the difference between muscle diseases and nerve diseases.
The Neuroline, Disposable Monopolar needle electrodes are made for muscle activity recording for Electromyography (EMG) applications. The electrodes are for single patient use only.
Product codes (comma separated list FDA assigned to the subject device)
GXZ
Device Description
The Ambu Neuroline Disposable Monopolar needle electrode is a Single Patient EMG needle electrode and is used to measure an EMG signal when connected to the EMG equipment. The Ambu Neuroline Disposable Monopolar needle is manufactured in different lengths and diameters.
The Ambu Neuroline Disposable Monopolar needle is connected to the EMG equipment through a 1.5 mm touch proof connector according to DIN 42 802 either with a pre-attached cable or as a non-cable version to be used with Ambu's reusable cable for the Ambu Neuroline Monopolar. The Ambu Neuroline Disposable Monopolar needle electrode is a sterile product.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
muscles
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The non-clinical tests performed are laboratory tests to verify the functionality of the Ambu Neuroline Disposable Monopolar needle electrode. The Ambu Neuroline Disposable Monopolar needle electrode is tested for penetration force, friction force and electrical properties. The verification of the sharpness and the friction of the needle was performed according to DIN 13097.
Ageing tests are performed to verify and ensure the functionality during the shelf life of the product.
No clinical tests were performed for the updated version of the Ambu Neuroline Disposable Monopolar needle because it has the same intended use and similar characteristics as the currently commercially available Ambu Neuroline Disposable Monopolar needle electrode.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.1350 Needle electrode.
(a)
Identification. A needle electrode is a device which is placed subcutaneously to stimulate or to record electrical signals.(b)
Classification. Class II (performance standards).
0
Revised Summary
Special 510(k) Application - Neuroline Disposable Monopolar needle electrode
510(k) Summary
MAY 3 0 2007
-
- 510(k) owner: Ambu A/S Baltorpbakken 13 DK-2750 Ballerup Denmark Tel.: +45 72252000 Fax.: +45 72252050
Contact person: Anne Bielefeldt Regulatory Affairs Specialist
- 510(k) owner: Ambu A/S Baltorpbakken 13 DK-2750 Ballerup Denmark Tel.: +45 72252000 Fax.: +45 72252050
-
- Preparation date of the 510(k) summary: April 2007
| 3. Name of device:
| Device Common name: | Disposable Monopolar needle electrode |
|---|---|
| 4. Device Trade name: | Neuroline, Disposable Monopolar needle |
| electrode | |
| 5. Classification Name: | Electrode, needle. |
| 21 CFR 882.1350 | |
| 6. Product Code: | GXZ |
7. Identifies the legally marketed device to which equivalence is claimed
| Manufacturer | Trade Name | Product code |
|---|---|---|
| Ambu A/S | Neuroline, Disposable | |
| Monopolar needle electrode | GXZ | |
| Viasys Healthcare Inc. | Medelec Elite Disposable | |
| Concentric Needle Electrode | IKT |
1
8. Description of device
The Ambu Neuroline Disposable Monopolar needle electrode is a Single Patient EMG needle electrode and is used to measure an EMG signal when connected to the EMG equipment. The Ambu Neuroline Disposable Monopolar needle is manufactured in different lengths and diameters.
The Ambu Neuroline Disposable Monopolar needle is connected to the EMG equipment through a 1.5 mm touch proof connector according to DIN 42 802 either with a pre-attached cable or as a non-cable version to be used with Ambu's reusable cable for the Ambu Neuroline Monopolar. The Ambu Neuroline Disposable Monopolar needle electrode is a sterile product.
9. The intended use
Ambu Neuroline Disposable Monopolar needle electrodes is used for electromyography (EMG) recording for examination of the peripheral neuromuscular system, by registration of the electrical activity from the muscles. This is used to assess whether muscle impairment is due to disturbances in the motor neurones, the motor nerve fibres or in the muscle itself. It is used mainly to tell the difference between muscle diseases and nerve diseases.
10. Indication for Use
The Neuroline, Disposable Monopolar needle electrodes are made for muscle activity recording for Electromyography (EMG) applications. The electrodes are for single patient use only.
11. Summary of the technological Characteristics
Ambu Neuroline Disposable Monopolar needle electrodes consist of a solid needle made from stainless steel coated with a low friction polymer. The Ambu Neuroline Disposable Monopolar needle electrode is used with a reference electrode and a ground electrode.
12. Brief discussion of the nonclinical tests submitted
The non-clinical tests performed are laboratory tests to verify the functionality of the Ambu Neuroline Disposable Monopolar needle electrode. The Ambu Neuroline Disposable Monopolar needle electrode is tested for penetration force, friction force and electrical properties. The verification of the sharpness and the friction of the needle was performed according to DIN 13097.
Ageing tests are performed to verify and ensure the functionality during the shelf life of the product.
13. Brief discussion of the clinical tests submitted
2
No clinical tests were performed for the updated version of the Ambu Neuroline Disposable Monopolar needle because it has the same intended use and similar characteristics as the currently commercially available Ambu Neuroline Disposable Monopolar needle electrode.
14. Biocompatibility testing
The biological safety of the Ambu Neuroline Disposable Monopolar needle electrode has been assured through the selection of materials, which demonstrate appropriate levels of biocompatibility. Tests were selected on the basis of ISO 10993-1 - Biological evaluation of Medical Device.
The following tests were performed and passed:
- Cytotoxicity assay in vitro
- Contact hypersensitivity in the guinea pig Maximization study
- Intracutaneous test in the rabbit
- Systemic Injection test in the mice
15.Conclusions drawn from the nonclinical, clinical and biocompatibility tests
From the results of the non clinical verification test and biocompatibility test, it has been concluded that Ambu Neuroline Disposable Monopolar Needle electrode fulfils the product specifications set for the design. It is concluded that Ambu Neuroline Disposable Monopolar Needle electrode is a safe and effective Monopolar needle electrode and comparable to the predicate devices.
3
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ambu Inc. c/o Mr. Sanjay Parikh Technical and Regulatory Affairs 6470 Baymeadow Drive Glen Burnie, Maryland 21060
MAY 3 0 2007
Re: K071185
Trade/Device Name: Neuroline, Disposable Monopolar needle electrode Regulation Number: 21 CFR 882.1350 Regulation Name: Needle electrode Regulatory Class: Class II Product Code: GXZ Dated: April 26, 2007 Received: April 30, 2007
Dear Mr. Parikh:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
4
Page 2 - Mr. Parikh
This letter will allow you to begin marketing your device as described in your Section 510(k) I ms letter will anow you to begin mailtoning your and equivalence of your device to a legally premaired predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific daries in your as the regulation of the regulation entitled, Connact the Office of Companisemarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small other general mionnation on your roopemer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours
for P.D.
Mark N. Melkerson
N.D. 5/25/07
Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Special 510(k) Application - Neuroline, Disposable Monopolar needle electrode
Indications for Use
510(k) Number: K071185
Device Name: Ambu Neuroline, Disposable Monopolar needle electrode
Indications For Use:
The Neuroline, Disposable Monopolar needle electrodes are made for muscle activity recording for Electromyography (EMG) applications. The electrodes are for single patient use only.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(Please Do Not WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Dir
Section D - Page 1 of __ 1 ____
Division of General, Restorative, and Neurological Devices
510(k) Number